A detailed history of Howard Hughes Medical Institute transactions in Moderna, Inc. stock. As of the latest transaction made, Howard Hughes Medical Institute holds 73 shares of MRNA stock, worth $2,079. This represents 0.0% of its overall portfolio holdings.

Number of Shares
73
Holding current value
$2,079
% of portfolio
0.0%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Aug 14, 2025

BUY
$23.65 - $28.54 $1,726 - $2,083
73 New
73 $2,000

Others Institutions Holding MRNA

About Moderna, Inc.


  • Ticker MRNA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 391,200,000
  • Market Cap $11.1B
  • Description
  • Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...
More about MRNA
Track This Portfolio

Track Howard Hughes Medical Institute Portfolio

Follow Howard Hughes Medical Institute and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Howard Hughes Medical Institute, based on Form 13F filings with the SEC.

News

Stay updated on Howard Hughes Medical Institute with notifications on news.